Post-Prostatectomy Outcomes Differ for Gleason 8, 9-10 Prostate Cancer
Patients with Gleason 9 or 10 prostate tumors have worse oncologic outcomes after radical prostatectomy (RP).
Patients with Gleason 9 or 10 prostate tumors have worse oncologic outcomes after radical prostatectomy (RP).
Radical prostatectomy (RP) is associated with excellent long-term outcomes in patients with localized prostate cancer (PCa).
Positive surgical margins alone do not influence overall survival among prostate cancer patients undergoing radical prostatectomy (RP).
Elevated neutrophil-lymphocyte ratio prior to radical prostatectomy for prostate cancer significantly associated with biochemical recurrence.
The 10-year rates of biochemical and clinical recurrence are comparable to those of open surgery.
Researchers have identified risk factors for the development of metastatic disease in prostate cancer (PCa) being managed with active surveillance.
Elevated neutrophil to lymphocyte ratio (NLR) may predict greater likelihood of tumor recurrence in non-muscle invasive bladder cancer (NMIBC).
Active surveillance is widely used by community-based urologists to manage newly diagnosed localized prostate cancer (PCa).
Pharmacologic inhibition of the renin-angiotensin system associated with improved patient outcomes in non-muscle invasive bladder cancer (NMIBC).
Patients who undergo radical prostatectomy for high-risk prostate cancer (PCa) seldom receive adjuvant radiation therapy (ART).